MergerLoop
  • Home
  • All deals
  • Newsletter
  • 20 weeks in report
Register

MergerLoop is a DDLoop project

Register

EMD Holdings NewCo Inc. 1653931500038 / Bio-Techne Corporation NASDAQ: TECH

Approved · Notification · Phase 1 · decided in 29 days, 8 Oct 2026

Wholesale & DistributionMN-25049ACCC register

German science and technology company Merck KGaA proposes to acquire US-based life sciences company Bio-Techne Corporation via a 100% share acquisition. This expands Merck's life science portfolio, covering biopharmaceutical manufacturing products and lab essentials, with Bio-Techne's reagents, analytical instruments, and precision diagnostics.

Timeline

  1. 9 Sept 2026Filed with the ACCC
  2. 8 Oct 2026Merck KGaA–Bio-Techne - Phase 1 determinationPDF · 154.0 KB

Acquisition details

Merck KGaA (Merck) proposes to acquire 100% of Bio-Techne Corporation (Bio-Techne)’s issued share capital through its wholly-owned subsidiary, EMD Holdings NewCo, Inc. (Merger Sub). Merck will acquire 100% of the outstanding common stock of Bio-Techne via a merger of Merger Sub with and into Bio-Techne with Bio-Techne surviving as a wholly-owned subsidiary of Merck. Merck is a global science and technology company (listed on the Frankfurt Stock Exchange: MRK) headquartered in Germany. Merck operates through three business sectors: its larger Life Science and Healthcare segments, as well as its smaller Electronics segment. Merck’s Life Science portfolio is primarily focused on products and technologies supporting biopharmaceutical manufacturing, while also offering a broad catalogue of biology and chemistry products, including reagents, solvents, filters and everyday lab essentials as well as specialised products and services such as contract testing services, biomonitoring and diagnostic and regulated materials. Bio-Techne is a publicly traded life sciences company (NASDAQ: TECH) headquartered in the United States, which specialises in reagents, analytical instruments, and precision diagnostics, supplying to academic researchers, biopharmaceutical companies, and clinical labs, among others. Both parties supply life science analytical instruments, protein analysis techniques, bioactive small molecules, antibodies, cell culture products and other consumables.

Parties

Acquirer
EMD Holdings NewCo Inc. 1653931500038
Target
Bio-Techne Corporation NASDAQ: TECH
Other parties
SIGMA-ALDRICH OCEANIA PTY LTD ABN 29 112 895 708, MERCK HEALTHCARE PTY LTD ABN 72 006 900 830, Merck KGaA HRB 6164, E. Merck KG HRA 3614, MERCK LIFE SCIENCE PTY LTD ABN 66 051 627 831
ANZSIC
  • 1841 Human Pharmaceutical and Medicinal Product Manufacturing
  • 2419 Other Professional and Scientific Equipment Manufacturing
  • 3323 Industrial and Agricultural Chemical Product Wholesaling
  • 3491 Professional and Scientific Goods Wholesaling
  • 3720 Pharmaceutical and Toiletry Goods Wholesaling
  • 6240 Financial Asset Investing

More Wholesale & Distribution deals

  • Rexel / Genuine Cable GroupWaiver · Approved
  • TD SYNNEX / BlueStarWaiver · Approved
  • Jaybro / Sewer Equipment Company AustraliaWaiver · Approved
  • Dicker Data / SektorWaiver · Approved
  • DCP Capital / VitacoWaiver · Approved
  • Brookfield Corporation / Reliance Worldwide CorporationWaiver · Approved